The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Pharmacy Team Combats COVID-19 in NYC: Q&A with Mark J. Sinnett, PharmD, FASHP

Pharmacy Team Combats COVID-19 in NYC: Q&A with Mark J. Sinnett, PharmD, FASHP

May 1, 2020 • By Mary Choy, PharmD, BCGP, FASHP

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The Montefiore Medical Center pharmacy team is a vital part of the frontline staff working to combat COVID-19 in New York City.

The outbreak of the SARS-CoV-2 virus is disrupting patient care all over the world. In the U.S., many providers have had to adapt to new social distancing measures to care for patients, but struggles remain. Mark J. Sinnett, PharmD, FASHP, director of clinical and educational pharmacy services and director of the Center for Pharmacotherapy Research and Quality (CPRQ) at Montefiore Medical Center, The Bronx, N.Y., recently spoke with The Rheumatologist about how the pandemic is affecting his medical institution. New York is now driving the national pandemic in the U.S., where it’s currently the epicenter of the COVID-19 outbreak.

You Might Also Like
  • COVID-19 Reality Check: Collected Stories from Rheumatologists & Rheumatology Professionals
  • Hydroxychloroquine for COVID-19 Fails Another Test
  • Hydroxychloroquine Tied to Increased Risk of Death in COVID-19 Patients

Q: How are you and your staff adapting to the sudden changes brought about by the pandemic?
As the impact of the COVID-19 pandemic continues to escalate, there has been a huge influx of COVID-19 patients at Montefiore Medical Center. It has required significant changes in staffing for our pharmacists and pharmacy technicians and a new and careful approach to how we dispense medications to these patients. This includes realigning our ambulatory care pharmacists and technicians to our inpatient pharmacy services, storage of medications in a manner that reduces the risk of infection for our pharmacy technicians and use of longer acting medications to reduce coronavirus exposure of our nurses. 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In an ironic way, although we practice social distancing and wear PPE [personal protective equipment], this pandemic has brought our staff closer together. We are here for our patients and for each other.

Mark J. Sinnett, PharmD, FASHP

Q: With social distancing, what types of appointments are you conducting? How are you dispensing medicines to patients and counseling them about their medications?
Our ambulatory pharmacy continues to see patients, both our healthcare workers, as well as patients who get discharged from the hospital. Since the outbreak, we limit the number of patients who can enter our pharmacy and counsel patients utilizing social distancing techniques. For patients who were discharged from the hospital with mild disease, we mail medications to them. These patients then do not have to return to the hospital and potentially infect other patients and healthcare workers.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Q: Have you seen any shortages of rheumatology-related drugs, such as hydroxychloroquine (HCQ) or others, that are being investigated as treatments for COVID-19?
Fortunately, we never experienced shortages of HCQ. However, we do experience sporadic shortages of other medications, such as tocilizumab (Actemra), anakinra (Kineret) and sarilumab (Kevzara). We look to enroll eligible patients in these investigational drug protocols whenever possible. Three such studies are randomized, placebo-controlled trials evaluating the efficacy of remdesivir, leronlimab and HCQ against the coronavirus.

Pages: 1 2 | Single Page

Filed Under: Drug Updates, Professional Topics Tagged With: Association of Rheumatology Professionals (ARP), coronavirus, COVID-19, Hydroxychloroquine (HCQ), pharmacy, sarilumab, tocilizumab

You Might Also Like:
  • COVID-19 Reality Check: Collected Stories from Rheumatologists & Rheumatology Professionals
  • Hydroxychloroquine for COVID-19 Fails Another Test
  • Hydroxychloroquine Tied to Increased Risk of Death in COVID-19 Patients
  • U.K. Healthcare Workers Begin COVID-19 HCQ Trial

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)